Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 133,487 |
|
|||||
| News | (2) | ||||||
| Day High | 0.829 | Low High |
|||||
| Day Low | 0.782 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aligos Therapeutics Inc | ALGS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0278 | -3.35% | 0.8012 | 19:47:56 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.81 | 0.782 | 0.829 | 0.818 | 0.829 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 400 | 133,487 | $ 0.8103732 | $ 108,174 | - | 0.5388 - 1.38 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:44:51 | formt | 299 | $ 0.8012 | USD |
Aligos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 60.53M | 75.67M | - | 15.53M | -87.68M | -1.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aligos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALGS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.7888 | 0.8977 | 0.73 | 0.807994 | 318,316 | 0.0124 | 1.57% |
| 1 Month | 0.9501 | 1.10 | 0.73 | 0.9394671 | 323,153 | -0.1489 | -15.67% |
| 3 Months | 0.6897 | 1.20 | 0.62 | 0.8935576 | 413,322 | 0.1115 | 16.17% |
| 6 Months | 0.6142 | 1.20 | 0.5438 | 0.7881772 | 346,400 | 0.187 | 30.45% |
| 1 Year | 1.01 | 1.38 | 0.5388 | 0.8695369 | 242,280 | -0.2088 | -20.67% |
| 3 Years | 24.68 | 34.31 | 0.5388 | 4.56 | 256,269 | -23.88 | -96.75% |
| 5 Years | 14.74 | 37.5099 | 0.5388 | 6.05 | 238,469 | -13.94 | -94.56% |
Aligos Therapeutics Description
| Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others. |
